Related references
Note: Only part of the references are listed.The role of LAT1 in 18F-DOPA uptake in malignant gliomas
Ryan S. Youland et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
18F-AFETP, 18F-FET, and 18F-FDG Imaging of Mouse DBT Gliomas
Kiran Kumar Solingapuram Sai et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Nutrient signaling to mTOR and cell growth
Jenna L. Jewell et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted Zr-89-Labeled Panitumumab
Tapan K. Nayak et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy
Mayumi Ohkawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
Stephen I. Rudnick et al.
CANCER RESEARCH (2011)
Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein
Takashi Masuko et al.
CANCER SCIENCE (2011)
AN INTERINDIVIDUAL COMPARISON OF O-(2-[18F]FLUOROETHYL)-L-TYROSINE (FET)- AND L-[METHYL-11C]METHIONINE (MET)-PET IN PATIENTS WITH BRAIN GLIOMAS AND METASTASES
Anca-Ligia Grosu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
In vivo biodistribution and accumulation of 89Zr in mice
Diane S. Abou et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: A possible target for combination therapy with anti-proliferative aminopeptidase inhibitors
Xuetao Fan et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
Maria J. W. D. Vosjan et al.
NATURE PROTOCOLS (2010)
Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung
Kyoichi Kaira et al.
CANCER SCIENCE (2009)
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Paul Nicklin et al.
CELL (2009)
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Eli C. F. Dijkers et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats
Tae Sup Lee et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Comparison of 18F-FET and 18F-FDG PET in brain tumors
Dirk Pauleit et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer
Takeshi Sakata et al.
PATHOLOGY INTERNATIONAL (2009)
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer
K. Kaira et al.
BRITISH JOURNAL OF CANCER (2008)
Production and characterization of highly tumor-specific rat monoclonal antibodies recognizing the extracellular domain of human L-type amino-acid transporter 1
Yoshiya Ohno et al.
CANCER SCIENCE (2008)
L-type amino acid transporters LAT1 and LAT4 in cancer:: Uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo
Cathleen Haase et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Blood-brain barrier transport of therapeutics via receptor-mediation
Angela R. Jones et al.
PHARMACEUTICAL RESEARCH (2007)
L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors
Hiroshi Nawashiro et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles
V Mishra et al.
JOURNAL OF DRUG TARGETING (2006)
Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime?
BC Fuchs et al.
SEMINARS IN CANCER BIOLOGY (2005)
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines
O Yanagida et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
PET imaging of musculoskeletal tumours with fluorine-18 α-methyltyrosine:: comparison with fluorine-18 fluorodeoxyglucose PET
H Watanabe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Share Paper
